Virginia Retirement Systems’s Aerie Pharmaceuticals AERI Stock Holding History

Virginia Retirement Systems’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$105K	Buy	+11,500	New	+$88.6K	﹤0.01%	1088

Other funds holding AERI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Virginia Retirement Systems's AERI Position: Q1 2022 in Review

Virginia Retirement Systems opened a new position in Aerie Pharmaceuticals (AERI) in Q1 2022: 11,500 shares worth $105K. The stake represents ﹤0.01% of the portfolio and ranks #1088 among its holdings.

136 funds tracked by Wall St. Rank hold AERI as of Q1 2022.

Virginia Retirement Systems held 11,500 shares of Aerie Pharmaceuticals worth $105K as of Q1 2022.
Aerie Pharmaceuticals was a new Virginia Retirement Systems position in Q1 2022.
Aerie Pharmaceuticals made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q1 2022, its #1088 holding.
136 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2022.

Based on Virginia Retirement Systems's 13F filing for Q1 2022, filed 21 Apr 2022.